UnitedHealth Takeover of EMIS Faces Further UK Competition Investigation
2023年3月31日 - 4:59PM
Dow Jones News
By Michael Susin
The U.K. Competition and Markets Authority said on Friday that
it will refer the UnitedHealth Group Inc.'s 1.24 billion-pound
($1.54 billion) deal to buy EMIS Group PLC to a phase two
investigation.
The CMA said that it has decided to refer the merger to a next
phase investigation after considering that initial undertakings
wouldn't achieve a reasonable solution following concerns that it
could reduce competition, leading to worse outcomes for the
National Health Service and patients and taxpayers.
In a separate statement, the companies said the decision was
disappointing and that they continue to believe that the proposed
remedy directly addresses the competition concerns raised by the
antitrust regulator.
Write to Michael Susin at michael.susin@wsj.com
(END) Dow Jones Newswires
March 31, 2023 03:44 ET (07:44 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
UnitedHealth (NYSE:UNH)
過去 株価チャート
から 3 2024 まで 4 2024
UnitedHealth (NYSE:UNH)
過去 株価チャート
から 4 2023 まで 4 2024
